- Report
- August 2022
- 148 Pages
Global
From €4939EUR$5,500USD£4,230GBP
- Report
- June 2024
- 150 Pages
Global
From €5344EUR$5,950USD£4,577GBP
- Report
- February 2022
- 172 Pages
Global
From €2685EUR$2,990USD£2,300GBP
- Report
- May 2024
- 134 Pages
Global
From €5837EUR$6,499USD£4,999GBP
- Report
- July 2023
- 140 Pages
Global
From €4445EUR$4,949USD£3,807GBP
- Report
- September 2022
- 239 Pages
Global
From €6736EUR$7,500USD£5,769GBP
- Report
- September 2022
- 116 Pages
Global
From €3547EUR$3,950USD£3,038GBP
- Report
- January 2022
- 60 Pages
Global
From €3547EUR$3,950USD£3,038GBP
- Report
- January 2022
- 60 Pages
Global
From €3547EUR$3,950USD£3,038GBP
- Report
- November 2021
- 156 Pages
Global
From €6242EUR$6,950USD£5,346GBP
- Report
- June 2024
- 200 Pages
Global
From €7140EUR$7,950USD£6,115GBP
- Report
- June 2024
- 200 Pages
Global
From €7140EUR$7,950USD£6,115GBP
- Report
- January 2022
- 60 Pages
Global
From €3547EUR$3,950USD£3,038GBP
- Report
- December 2024
- 85 Pages
Spain
From €2672EUR$2,975USD£2,288GBP
€3143EUR$3,500USD£2,692GBP
- Report
- May 2024
- 184 Pages
Global
From €3435EUR$3,825USD£2,942GBP
€4041EUR$4,500USD£3,461GBP
- Report
- November 2023
- 77 Pages
France
From €2672EUR$2,975USD£2,288GBP
€3143EUR$3,500USD£2,692GBP
- Report
- October 2023
- 138 Pages
North America
From €3053EUR$3,400USD£2,615GBP
€3592EUR$4,000USD£3,077GBP
- Report
- April 2022
- 358 Pages
Global
From €3435EUR$3,825USD£2,942GBP
€4041EUR$4,500USD£3,461GBP
- Report
- June 2024
- 165 Pages
Global
From €2245EUR$2,500USD£1,923GBP
- Report
- April 2023
- 110 Pages
Global
From €4266EUR$4,750USD£3,654GBP

The Head and Neck Cancer Drug market is a subset of the larger Oncology Drugs market. It includes drugs used to treat cancers of the head and neck, such as squamous cell carcinoma, salivary gland cancer, and nasopharyngeal cancer. These drugs are typically used in combination with radiation therapy and/or surgery to treat the cancer. Common drugs used in this market include chemotherapy, targeted therapy, immunotherapy, and monoclonal antibodies.
The Head and Neck Cancer Drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in this market include Bristol-Myers Squibb, Merck & Co., Pfizer, AstraZeneca, and Roche. Other companies include Novartis, Eli Lilly, and GlaxoSmithKline. Show Less Read more